ALX Oncology News - ALXO

Company Name	Stock Ticker Symbol	Market	Type
ALX Oncology Holdings Inc	ALXO	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-1.37	-8.78%	14.23	16:31:35

Open Price	Low Price	High Price	Close Price	Prev Close
15.60	13.88	15.73	14.23	15.60

more quote information »

Recent News

Date	Time	Source	Heading
4/22/2024	8:49	IHNW	FeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
4/09/2024	17:30	GLOBE	ALX Oncology Reports Encouraging Clinical Data of Evorpacept..
3/07/2024	16:05	EDGAR2	Form 8-K - Current report
3/07/2024	16:03	GLOBE	ALX Oncology Reports Fourth Quarter and Full Year 2023..
3/05/2024	16:30	GLOBE	ALX Oncology Announces Two Evorpacept Clinical Abstracts..
2/16/2024	18:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/16/2024	18:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/16/2024	18:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/05/2024	16:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	16:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/03/2024	08:00	GLOBE	ALX Oncology to Present at the 42nd Annual J.P. Morgan..
12/26/2023	16:01	EDGAR2	Form 8-K - Current report
11/13/2023	16:05	GLOBE	ALX Oncology Reports Third Quarter 2023 Financial Results..
11/13/2023	16:03	EDGAR2	Form 8-K - Current report
11/01/2023	16:05	GLOBE	ALX Oncology Announces November Investor Conference..
10/10/2023	16:05	GLOBE	ALX Oncology Announces Closing of Public Offering, Including..
10/06/2023	06:06	EDGAR2	Form 8-K - Current report
10/06/2023	06:05	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/05/2023	08:00	GLOBE	ALX Oncology Announces Pricing of Public Offering
10/04/2023	17:21	EDGAR2	Form 8-K - Current report
10/04/2023	17:21	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
10/04/2023	16:10	GLOBE	ALX Oncology Announces Proposed Public Offering
10/04/2023	08:00	EDGAR2	Form 8-K - Current report
10/03/2023	10:03	IHMARKETNEWS	Keep An Eye Out: Pre-Market Movers And Recommendations
10/03/2023	06:00	GLOBE	ALX Oncology Reports Positive Interim Phase 2 ASPEN-06..
10/02/2023	16:05	GLOBE	ALX Oncology to Host Investor Call and Webcast on October 3,..
9/20/2023	08:45	IHNW	Pathways to Progress: How Orphan Drug Designation Sparks..
9/11/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
9/08/2023	16:25	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
9/06/2023	16:05	EDGAR2	Form 8-K - Current report
9/06/2023	08:00	GLOBE	ALX Oncology Realigns Executive Leadership Team
9/01/2023	16:11	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/31/2023	07:00	GLOBE	ALX Oncology Announces September Investor Conference..
8/25/2023	16:44	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/10/2023	16:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	16:05	EDGAR2	Form 8-K - Current report
8/10/2023	16:01	GLOBE	ALX Oncology Reports Second Quarter 2023 Financial Results..
7/27/2023	16:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/27/2023	16:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/27/2023	16:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/07/2023	16:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	17:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	17:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/05/2023	17:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/26/2023	07:00	GLOBE	ALX Oncology Receives Orphan Drug Designation from the..
5/11/2023	16:01	GLOBE	ALX Oncology Reports First Quarter 2023 Financial Results..
5/09/2023	07:00	GLOBE	ALX Oncology Announces First Patient Dosed in Phase 2..
4/25/2023	07:00	GLOBE	ALX Oncology Announces Clinical Trial Collaboration with..